Consumer Staples Sector Outperforms, ETF (XLP) Climbs 1.25%

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/15/2026

1. NVDA
2. DPZ
3. DRS
4. GS
5. BAC
6. UNH
7. ORCL
8. AVAV
9. ACI
10. META

Go back to Consumer Staples Sector Outperforms, ETF (XLP) Climbs 1.25%

Johnson & Johnson's (JNJ) Potential to Change Multiple Myeloma Treatment Paradigm in Underappreciated, Stock Remains Top Pick - Cantor Fitzgerald

January 24, 2022 6:24 AM EST

Cantor Fitzgerald analyst Louise Chen reiterated an Overweight rating and $215.00 price target on Johnson & Johnson (NYSE: JNJ) in light of the upcoming PDUFA for the company's CAR-T therapy.

The analyst quotes: "The PDUFA date for Johnson and Johnson (JNJ) and Legend Biotech's BCMA (B-cell... More